WORLD
FDA Says Current Dose of GSK-Vir COVID Therapy Unlikely to Work Against BA.2 Variant - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'FDA says current dose of GSK-Vir COVID therapy unlikely to work against BA.2 variant ...'
FDA says current dose of GSK-Vir COVID therapy unlikely to work against BA.2 variant https://t.co/53NNOYoAyu pic.twitter.com/t15x1SQ32J— Reuters (@Reuters) March 25, 2022
(The above story first appeared on LatestLY on Mar 26, 2022 03:21 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
